⌘K

07:05:00·362d

PRReleasevia Quantisnow

Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion

ByQuantisnow·Wall Street's wire, on your screen.

RPRX· Royalty Pharma plc

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Weatherman Elizabeth H was granted 4,545 units of Class A Ordinary Shares, increasing direct ownership by 53% to 13,103 units (SEC Form 4)
Director Norden Gregory was granted 4,545 units of Class A Ordinary Shares, increasing direct ownership by 2% to 196,348 units (SEC Form 4)
Director Love Ted W was granted 4,545 units of Class A Ordinary Shares, increasing direct ownership by 8% to 58,393 units (SEC Form 4)
Director Hodgson David C was granted 4,545 units of Class A Ordinary Shares, increasing direct ownership by 14% to 37,873 units (SEC Form 4)
Director Ho Carole was granted 4,545 units of Class A Ordinary Shares (SEC Form 4)